Close Menu

OptiGene

The device, available for license from the Lawrence Livermore National Laboratories Industrial Partnerships Office, integrates a single-tube nucleic acid extraction method with loop-mediated isothermal amplification or reverse transcriptase LAMP.

OptiGene has licensed Eiken's loop-mediated isothermal amplification method to use in nucleic acid amplification reagents for infectious disease testing; while the UK's VLA has licensed the technology for veterinary testing and environmental monitoring.

OptiGene will develop, manufacture, and sell nucleic acid amplification reagents for research use, and VLA will develop, manufacture, and provide testing for nucleic acid diagnostics for veterinary purposes and environmental monitoring.

The platform will be based on isothermal amplification and its developers aim to cut the amount of time it takes to diagnose STDs to 15 minutes or less at the point of care.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.